Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

RTTNews | 950天前
Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

(RTTNews) - Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).

The complete response letter states that the FDA cannot approve the application in its present form. The FDA acknowledged that the study submitted in the New Drug Application (NDA) met its objective of bioequivalence based on area under the curve (AUC) parameters but identified additional requirements for approval.

Incyte intends to meet with the FDA to determine appropriate next steps.

The NDA was based on two studies designed to show that ruxolitinib XR tablets are dosage strength proportional and bioequivalent to Jakafi (ruxolitinib) tablets.

read more
Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.
RTTNews | 624天前
Incyte Q1 Results Top Estimates

Incyte Q1 Results Top Estimates

Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.
RTTNews | 1184天前
Japanese Market Modestly Lower

Japanese Market Modestly Lower

The Japanese market is modestly lower in choppy trading on Thursday, reversing some of the sharp gains in the previous session, following the mixed cues from Wall Street overnight. The Nikkei 225 is falling well below the 51,150 level, with weakness in index heavyweights and automaker stocks partially offset by gains in financial and technology stocks.
RTTNews | 1小時32分鐘前
China Bourse May Slip Beneath 4,000-Point Level

China Bourse May Slip Beneath 4,000-Point Level

The China stock market bounced higher again on Wednesday, one day after ending the three-day winning streak in which it had collected more than 80 points or 2 percent. The Shanghai Composite Index now sits just above the 4,015-point plateau although it may head south again on Thursday.
RTTNews | 1小時55分鐘前
Australian Market Modestly Lower

Australian Market Modestly Lower

The Australian market is trading modestly lower on Thursday, adding to the losses in the previous two sessions, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,900 level, with gains in iron ore miners and financial partially offset by weakness in technology stocks.
RTTNews | 2小時3分鐘前
Taiwan Bourse May Remain Rangebound On Thursday

Taiwan Bourse May Remain Rangebound On Thursday

The Taiwan stock market has moved higher in two of three trading days since the end of the two-day slide in which it had slumped more than 220 points or 0.8 percent. The Taiwan Stock Exchange now sits just shy of the 28,300-point plateau although it may tick lower again on Thursday.
RTTNews | 2小時30分鐘前
Singapore Shares May See Continued Consolidation

Singapore Shares May See Continued Consolidation

The Singapore stock market on Wednesday snapped the six-day winning streak in which it had jumped more than 120 points or 2.9 percent. The Straits Times Index now sits just above the 4,440-point plateau and it may take further damage on Thursday.
RTTNews | 2小時55分鐘前